Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:185-193
Published online before print July 5, 2005, doi: 10.1161/CIRCULATIONAHA.104.496075
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
112/2/185    most recent
CIRCULATIONAHA.104.496075v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ellervik, C.
Right arrow Articles by Nordestgaard, B. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ellervik, C.
Right arrow Articles by Nordestgaard, B. G.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Attack
*Hemochromatosis
Related Collections
Right arrow Clinical genetics
Right arrow Chronic ischemic heart disease
Right arrow Epidemiology
Right arrowRelated Article

(Circulation. 2005;112:185-193.)
© 2005 American Heart Association, Inc.


Epidemiology

Hereditary Hemochromatosis and Risk of Ischemic Heart Disease

A Prospective Study and a Case-Control Study

Christina Ellervik, MD; Anne Tybjærg-Hansen, MD, DMSc; Peer Grande, MD, DMSc; Merete Appleyard; Børge G. Nordestgaard, MD, DMSc

From the Department of Clinical Biochemistry, Herlev University Hospital (C.E., B.G.N.), Department of Clinical Biochemistry (A.T.-H.), and Department of Cardiology (P.G.), Rigshospitalet, Copenhagen University Hospital, and The Copenhagen City Heart Study, Bispebjerg University Hospital (A.T.-H., M.A., B.G.N.), University of Copenhagen, Copenhagen, Denmark.

Correspondence to Børge G. Nordestgaard, MD, DMSc, Department of Clinical Biochemistry, Herlev University Hospital, Herlev Ringvej 75, DK-2730 Herlev, Denmark. E-mail brno{at}herlevhosp.kbhamt.dk

Received July 29, 2004; revision received March 11, 2005; accepted March 29, 2005.

Background— We tested the hypothesis that the hereditary hemochromatosis genotypes C282Y/C282Y, C282Y/H63D, or C282Y/wild-type are risk factors for ischemic heart disease (IHD) and myocardial infarction (MI).

Methods and Results— We performed a prospective study of 9178 individuals from the Danish general population followed up for 24 years, during which 1035 and 511 developed IHD and MI, respectively, and a case-control study of 2441 and 1113 IHD and MI cases versus 8080 controls. C282Y/C282Y, C282Y/H63D, and C282Y/wild-type versus wild-type/wild-type individuals were not associated with increased risk of IHD or MI in prospective studies, overall or stratified by gender. We had 90% power to detect a hazard ratio for IHD of 3.4 for C282Y/C282Y, 1.9 for C282Y/H63D, and 1.3 for C282Y/wild-type versus wild-type/wild-type. Furthermore, these genotypes were not associated with increased risk of IHD or MI in case-control studies, overall or stratified by gender. We had 90% power to detect an odds ratio for IHD of 3.6 for C282Y/C282Y, 1.8 for C282Y/H63D, and 1.3 for C282Y/wild-type versus wild-type/wild-type.

Conclusions— In these studies, hereditary hemochromatosis C282Y/C282Y, C282Y/H63D, and C282Y/wild-type genotypes were not associated with IHD or MI; however, the study lacked the power to exclude the possibility that C282Y/C282Y and C282Y/H63D individuals have a modestly increased risk of IHD or MI.


Key Words: cardiovascular diseases • prospective studies • case-control studies • hemochromatosis


Related Article:

Issue Highlights
Circulation 2005 112: 147. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Circ Cardiovasc GenetHome page
P. C. Adams, J. S. Pankow, J. C. Barton, R. T. Acton, C. Leiendecker-Foster, G. D. McLaren, M. Speechley, and J. H. Eckfeldt
HFE C282Y Homozygosity Is Associated With Lower Total and Low-Density Lipoprotein Cholesterol: The Hemochromatosis and Iron Overload Screening Study
Circ Cardiovasc Genet, February 1, 2009; 2(1): 34 - 37.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. Ellervik, A. Tybjaerg-Hansen, M. Appleyard, H. Sillesen, G. Boysen, and B. G. Nordestgaard
Hereditary hemochromatosis genotypes and risk of ischemic stroke
Neurology, March 27, 2007; 68(13): 1025 - 1031.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
F. B. Hu
The Iron-Heart Hypothesis: Search for the Ironclad Evidence
JAMA, February 14, 2007; 297(6): 639 - 641.
[Full Text] [PDF]


Home page
CirculationHome page
S. Goland, S. D. Malnick, C. Ellervik, B. G. Nordestgaard, A. Tybjaerg-Hansen, P. Grande, A. Tybjaerg-Hansen, M. Appleyard, and B. G. Nordestgaard
Letter Regarding Article by Ellervik et al, "Hereditary Hemochromatosis and Risk of Ischemic Heart Disease: A Prospective Study and a Case-Control Study" * Response
Circulation, January 3, 2006; 113(1): e10 - e10.
[Full Text] [PDF]